| T1015 | Clinic visit/encounter, all-inclusive | 22,940 | $100 | $2.3M |
| 87636 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, and influenza B using a multiplex amplified nucleic… | 340 | $90 | $32K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 10,670 | $1 | $21.3K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 110 | $60 | $6.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 5,420 | $1 | $5.4K |
| 90649 | This code represents a quadrivalent human papillomavirus (HPV) vaccine product administered into the muscle to protect against HPV infection. The vaccine protects against four HPV types (6, 11, 16,… | 150 | $20 | $2.5K |
| 87811 | The lab analyst performs the technical lab test to analyze for the presence of severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) (Coronavirus disease [COVID–19]) in a specimen by… | 50 | $30 | $1.5K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 90 | $10 | $850 |
| 90734 | The provider administers a meningococcal conjugate vaccine in a diphtheria toxoid carrier (MenACWY–D) or CRM197 carrier (MenACWY–CRM) to protect the patient from four strains of meningococcal viruses… | 30 | $20 | $600 |
| 99394 | The provider performs an established well–patient visit for an adolescent who is between the ages of 12 and 17. | 460 | $1 | $460 |